Management Plan for Severe Preeclampsia at 33 Weeks Gestation
Immediate Blood Pressure Management
Your patient requires urgent continuation of IV antihypertensive therapy with a target BP of 140-150/90-105 mmHg, ongoing MgSO4 for seizure prophylaxis, and close maternal-fetal monitoring with delivery planning based on maternal stability and fetal status. 1, 2
Current Acute BP Control
- The AC (likely labetalol or hydralazine) drip initiated by OB is appropriate for BP ≥160/110 mmHg, which represents a hypertensive emergency requiring treatment within 60 minutes 2
- Target BP should be systolic 140-150 mmHg and diastolic 90-105 mmHg to prevent maternal stroke while maintaining placental perfusion 1, 2
- Monitor BP every 5-10 minutes during acute treatment phase 2
- If current IV agent is ineffective, acceptable alternatives include:
Critical Safety Considerations
- Avoid combining nifedipine with MgSO4 due to risk of precipitous hypotension 2
- Labetalol is contraindicated if patient has asthma, heart block, or decompensated heart failure 2
- Never use sublingual nifedipine due to uncontrolled hypotension risk 2
Magnesium Sulfate Continuation
Continue MgSO4 for seizure prophylaxis as this patient has severe hypertension with preeclampsia 1
- MgSO4 is indicated for women with preeclampsia who have proteinuria and severe hypertension, or hypertension with neurological signs/symptoms 1
- MgSO4 prevents eclampsia, halving the seizure rate (approximately 100 women need treatment to prevent 1 seizure) 1
- Continue throughout labor and for at least 24 hours postpartum 3
Corticosteroid Administration
The dexamethasone initiated by OB is appropriate for fetal lung maturity at 33 1/7 weeks gestation 4
- Steroids are effective in reducing neonatal mortality and morbidity when administered between 24-34 weeks' gestation in severe preeclampsia 3
- Complete the full course as planned 4
Maternal Monitoring Protocol
Implement intensive maternal surveillance with the following schedule: 1
- BP monitoring: Continuous or every 4 hours minimum while awake 1
- Clinical assessment: Check for clonus, headache, visual changes, right upper quadrant pain at least twice daily 1
- Laboratory tests (minimum twice weekly): 1
- Complete blood count with platelet count
- Liver transaminases (AST/ALT)
- Serum creatinine
- Uric acid
- Hemoglobin
- Repeat labs immediately if clinical status changes 1
- Assess for proteinuria if not already documented 1
- Monitor oxygen saturation and consider ICU transfer if <90% 5
Fetal Monitoring Protocol
Establish comprehensive fetal surveillance: 1
- Initial assessment: Confirm fetal well-being with non-stress test and biophysical profile 1
- Ultrasound evaluation: Assess fetal biometry, amniotic fluid volume, and umbilical artery Doppler 1
- Ongoing surveillance:
- Continuous fetal heart rate monitoring during acute BP management 2
Expectant Management vs. Delivery Decision
At 33 1/7 weeks with severe preeclampsia, pursue conservative expectant management at a center with Maternal-Fetal Medicine expertise UNLESS maternal or fetal indications for delivery emerge 1
Absolute Indications for Immediate Delivery (regardless of gestational age): 1
- Inability to control BP despite ≥3 classes of antihypertensives in appropriate doses
- Progressive thrombocytopenia (platelets <100,000/µL)
- Progressively abnormal liver function tests (transaminases >2x upper limit normal)
- Progressive renal dysfunction (creatinine >1.1 mg/dL or doubling of baseline)
- Pulmonary edema or maternal oxygen saturation <90%
- Severe persistent headache, repeated visual scotomata, or eclampsia
- Severe persistent right upper quadrant pain
- Placental abruption
- Non-reassuring fetal status (reversed end-diastolic flow on umbilical artery Doppler, non-reassuring cardiotocograph, or stillbirth)
If Maternal-Fetal Status Remains Stable:
- Continue expectant management until 34 weeks' gestation (after completing steroid course) 1
- Plan delivery at 37 weeks if condition remains stable without severe features 1
Transition to Maintenance Antihypertensive Therapy
Once acute BP control achieved, transition to oral antihypertensives: 1, 2
- First-line oral agents: 1
- Methyldopa
- Labetalol (if no contraindications)
- Long-acting nifedipine
- Oxprenolol
- Target diastolic BP of 85 mmHg in office (systolic 110-140 mmHg) 1
- Reduce or cease antihypertensives if diastolic BP falls <80 mmHg 1
- Treat persistent BP ≥140/90 mmHg to reduce likelihood of severe hypertension and complications 1
Hospital Setting Requirements
This patient requires inpatient management at a facility with: 1
- Maternal-Fetal Medicine expertise for preeclampsia <34 weeks
- Neonatal intensive care unit capabilities
- 24-hour anesthesia and operative delivery availability
- Ability to perform continuous maternal-fetal monitoring
Common Pitfalls to Avoid
- Do not use BP level alone to stratify risk - some women develop serious organ dysfunction at relatively mild BP levels 1
- Do not attempt to classify as "mild vs. severe" preeclampsia clinically - all cases may become emergencies rapidly 1
- Do not use serum uric acid or level of proteinuria as indications for delivery 1
- Do not manage expectantly at BP ≥160/110 mmHg but emergently treat it - this is logically inconsistent 1
- Do not discharge to outpatient management until maternal condition is clearly stable and patient can reliably report problems and monitor BP 1
Postpartum Planning
Prepare for high-risk postpartum period: 5, 4
- Preeclampsia can worsen or initially present after delivery 4
- Monitor as inpatient or closely at home for minimum 72 hours postpartum 4
- Continue antihypertensive medications with gradual tapering rather than abrupt cessation 5
- BP monitoring at least every 4 hours while awake for first 3 days 5
- Avoid NSAIDs for analgesia unless other options ineffective 5